# Study of Felzartamab in Healthy Adult Subjects

> **NCT06285201** · PHASE1 · COMPLETED · sponsor: **TJ Biopharma Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** T
- **DRUG:** R

## Key facts

- **NCT ID:** NCT06285201
- **Lead sponsor:** TJ Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-27
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285201, "Study of Felzartamab in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06285201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*